Gardasil has long been a pet hate in radfem circles, even though it was primarily promoted to cut down on the number of cervical cancers (that part is a good thing).
When the vaccination roll-out first happened the programme was only targeting teenage girls. A bit of dumb concept considering heterosexual intercourse was the main transmission route of the Human Papillomavirus (HPV), linked to cervical cancer. Logic would dictate that if they were serious about it, they would be injecting the teenage boys as well, for a greater population immunity. Logic would also dictate that the spread of HPV (and most STDs) travels more easily from the male to the female, after all, ejaculate is big gollup of potentially disease-carrying gunk and designed to be mobile.
Some places are now rolling out vaccination programmes for the boys. I gather the ‘live population trial’ among teenaged girls proved that vast numbers of them weren’t dropping dead from Gardasil. Yes, of course the teenaged girls were used as guinea pigs in this Gardasil experiment, hence the first objection of radfems. Secondly, it only protected against a limited number of strains of HPV. Thirdly, it gives a false sense of ‘security’ of protection against STDs in general, making condom use for casual sex less likely, and enabling greater likelihood of transmission of other STDs or other strains of HPV.
All of this crap is of course, pushing the sex-mozzer PIV agenda, enabling sexual access of females for recreation purposes. Surely the rate of STDs must be a red-flag by Mother Nature that PIV for recreation and with vast numbers of partners is NOT the way forward. Previous ‘sexual revolution’ rubbish, pushing the PIV agenda was the development of the oral contraceptive pill. All contraceptives have a failure rate, and it is always the female that carries the most risk of pregnancy or diseases.
Jilla alerted me to a new piece of propaganda around Gardasil and HPV, the full article below. It seems *shock horror* that males are presenting with increased number of cases of throat cancers linked to HPV. Males between the ages of 40-55 are the majority of these cases.
So, theories abound as to why various throat cancers are on the increase. I know, lets somehow blame women for it! One of their pet theories is that males are performing cunnilingus on females, and that is how they are getting HPV. I can tell you from my former het life, getting males to perform cunnilingus basically requires putting a gun to their head, very few do it willingly. Another theory floated was that it could be transmitted by kissing. Well, nice try, but you would expect equal numbers of females and males affected if that was the case, major logic fail.
There is only one conclusion that makes any sense in all of this – males are, sucking cock on the side. They are probably engaging in other male homosexual practices as well (anal sex), but the whole thing is remarkably hush-hush. These supposedly heterosexual (sometimes openly bisexual) males are engaging in both homosexual practices and heterosexual promiscuity, then coming home to their wives and girlfriends and transmitting the diseases to them. Yet another example of why “what people do in private is their business” is also a logic fail.
A sharp rise in a type of throat cancer among men is increasingly being linked to HPV, the sexually transmitted human papillomavirus that can cause cervical cancer in women.
A new study from the National Cancer Institute warns that if recent trends continue, the number of HPV-positive oral cancers among men could rise by nearly 30% by 2020. At that rate, it could surpass that of cervical cancers among women, which are expected to decline as a result of better screening.
The study is to be presented this week at the annual American Society of Clinical Oncology meeting.
Between 1988 and 2004, the researchers found, the incidence of HPV-positive oropharynx cancers—those that affect the back of the tongue and tonsil area—increased by 225%. Anil Chaturvedi, a National Cancer Institute investigator who led the research, estimates there were approximately 6,700 cases of HPV-positive oropharynx cancers in 2010, up from 4,000 to 4,500 in 2004, and cases are projected to increase 27% to 8,500 in 2020.
Recent studies show about 25% of mouth and 35% of throat cancers are caused by HPV, according to the Centers for Disease Control and Prevention.
Men account for the majority of cases, and currently the highest prevalence is in men 40 to 55, says Eric Genden, chief of head and neck oncology at Mount Sinai Medical Center in New York. Studies have shown that the cancer can show up 10 years after exposure to HPV, which has become the most common sexually transmitted virus in the U.S.
“We are sitting at the cusp of a pandemic,” says Dr. Genden.
Dr. Chaturvedi says more studies are needed to evaluate whether a vaccine now used to prevent HPV for genital warts and genital and anal cancers can prevent oral HPV infections.
The HPV vaccine, Gardasil, made by Merck & Co., was approved in 2006 for girls and young women up to age 26, but while it is routinely recommended, only about 27% of girls have received all three doses needed to confer protection.
The FDA in 2009 approved the vaccine for males ages 9 through 26 to reduce the risk of genital warts, and in 2010 approved it for both sexes for the prevention of anal cancers. However, the CDC has only a “permissive” recommendation for boys, rather than a routine recommendation, meaning doctors generally will only administer it if parents or patients ask for it, says Michael Brady, chairman of the American Academy of Pediatrics infectious disease committee.
Lauri Markowitz, a CDC medical epidemiologist, says the CDC advisory committee that sets vaccine recommendations will review new data related to the issue at a meeting next month. However, at present there aren’t any clinical-trial data showing the effectiveness of the vaccine against oral infections, she says.
A Merck spokeswoman says the company has no plans to study the potential of Gardasil to prevent these cancers.
Researchers say it isn’t clear why men are at higher risk for HPV-positive oral cancers. But for both men and women a high lifetime number of sex partners is associated with the cancer.
Changes in sexual behaviors that include increased practice of oral sex are associated with the increase, but a 2007 New England Journal of Medicine article also said engagement in casual sex, early age at first intercourse, and infrequent use of condoms each were associated with HPV-positive oropharyngeal cancer. Mouth-to-mouth contact through kissing can’t be ruled out as a transmission route.
Most infections don’t cause symptoms and go away on their own. But HPV can cause genital warts and warts in the throat, and has been associated with vaginal, vulvar and anal cancers.
Anna Giuliano, chairwoman of the department of cancer epidemiology at the Moffitt Cancer Center in Tampa, Fla., who studies oral HPV infections of men in several countries, says the rise in cancers among men shows it is important for males, as well as girls, to be vaccinated.
Doctors typically don’t test for HPV-positive oral cancers. But Jonathan Aviv, director of the voice and swallowing center at New York’s ENT and Allergy Associates, says his group looks through a miniature camera inserted through the nose at the back of the throat and tongue, and can biopsy suspicious warts or tumors.
In addition to being asked about symptoms such as hoarseness, difficulty swallowing, a neck mass or mouth sore that won’t heal, patients are asked to fill out a risk-assessment sheet that includes the number of lifetime oral-sex partners. “People do get upset sometimes, but if your sexual history puts you at an increased risk for HPV, you should go and see an ear, nose and throat doctor,” says Dr. Aviv.
Fortunately, says Mount Sinai’s Dr. Genden, those with HPV-positive oral cancers have a disease survival rate of 85% to 90% over five years, higher than those with oral cancers that aren’t linked to HPV, but are more commonly linked to alcohol use, tobacco, and radiation exposure.
Philip Keane, a 52-year-old photographer and partner in a marketing firm, found a lump on his neck while shaving, which was initially misdiagnosed as an infection. A scope of his throat showed it was HPV-positive throat cancer. Dr. Genden removed it last July using minimally invasive robotic surgery, and Mr. Keane had 6½ weeks of daily radiation after that, which left him cancer-free.
At first surprised and embarrassed, Mr. Keane says he has no reason to think he was at high risk; while he has young daughters who have been immunized, “I didn’t know about HPV in men.” He plans to have his 12-year-old son immunized as well.
And another article on HPV and anal cancer:
Gardasil, the human papillomavirus vaccine, has been given approval by the U.S. Food and Drug Administration (FDA) for prevention of cancer of the anus and related precancerous lesions, the agency said in a news release today. The FDA has previously approved Gardasil for cervical, vaginal and vulvar cancers in women and also for genital warts in both men and women. Both the old and new indications for the drug covers those aged 9 to 26. Four types of human papillomavirus (HPV) namely 6, 11, 16 and 18 are responsible for 90 percent of malignancies of the anal region. “Treatment for anal cancer is challenging; the use of Gardasil as a method of prevention is important as it may result in fewer diagnoses and the subsequent surgery, radiation or chemotherapy that individuals need to endure,” said Dr. Karen Midthun in a statement. She is the director of the Center for Biologics Evaluation and Research of the FDA.
The agency based the decision to expand the use of the vaccine partly on Merck’s study which showed that Gardasil was 78 percent effective in preventing the development of that type of cancer among men and women homosexuals. This new indication is for a cancer type that is rare but increasing. The National Cancer Institute says that about 5,300 people are diagnosed and 72 die annually from the disease. The incidence of this cancer is higher among men who have sexual intercourse with men where 40 cases for every 100,000 are documented. For those with HIV among the same group, the rate rises further to 80 for every 100,000 cases. The Advisory Committee on Immunization Practices has yet to decide on recommending vaccination for young men and women.
Because males will bum and suck each other off, even if they claim to be heterosexual. You cannot trust them to tell the truth about their sexual history or practices.